SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that Medicare reimbursement for CorMedixs DefenCath could fall sharply in 2027 has fueled a steep selloff and concern about future pricing and sales. Traders dispute how conclusive DaVitas estimate is, pointing to CMSs finalized payment rate and arguing the outlook depends on quarterly calculations and DefenCath uptake.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA approval of Inovios competing RRP treatment has put Precigens PAPZIMEOS under scrutiny, with traders debating whether the new option will erode its market position. Some fear stronger competition, while others point to Precigens first-mover and full-approval advantages and question Inovios ability to commercialize its drug.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results, supported by Eylea HD and Dupixent-related collaboration revenue, are driving a sharp breakout to multiyear highs. Traders are broadly bullish on the results and follow-through, while some question whether the gains will hold.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is drawing attention after Brazil approved its Valaris merger, which traders see as a step toward closing the deal, alongside recent offshore contract wins and higher day-rate expectations. Bulls anticipate improved scale and a potential short squeeze, while skeptics point to merger-related dilution, debt and the upcoming earnings report.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopifys integration with Metas Muse AI agent, which can route purchases through Shop Pay, has fueled discussion about whether agentic commerce will expand Shopifys role in online shopping or threaten traditional storefronts. Traders are also debating the stocks sharp, volatile pullback, with some looking ahead to earnings and others concerned about valuation and whether AI-related growth will translate into revenue.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,942,077.7905448. The last known price of Zcash is 1,263.32437248 USD and is up 2.82 over the last 24 hours. It is currently trading on 668 active market(s) with $1,115,981,976.30 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp rebound and resilience amid broader crypto weakness and Binance hack fears have traders highlighting its privacy features and speculating about a safe-haven shift into ZEC; some also point to the upcoming NU7 upgrade. Others view the rally as overextended and expect further declines.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A stronger-than-expected quarterly report and higher full-year revenue outlook, powered by demand for Mounjaro and Zepbound, have fueled LLYs rally and record highs. Traders are largely positive and cite analyst upgrades, while some question the valuation and point to trimmed profit guidance tied to acquisition-related research charges.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A rally to a fresh 52-week high ahead of an expected quarterly report has traders focused on BRIUMVI growth and whether results can justify the run; some expect an earnings-driven move, while others warn the stock may be priced for a beat. Buyout speculation and possible short covering are also fueling bullish chatter, but no deal is confirmed and the earnings timing remains uncertain.

BankrCoin (BNKR) is a cryptocurrency and operates on the Base platform. BankrCoin has a current supply of 100,000,000,000 with 99,389,999,999.99966667 in circulation. The last known price of BankrCoin is 0.00029512 USD and is up 9.48 over the last 24 hours. It is currently trading on 84 active market(s) with $2,292,823.67 traded over the last 24 hours. More information can be found at https://warpcast.com/bankr.

BankrCoin

Traders are focused on Bankrs expanding AI-agent infrastructure and ecosystem integrations, alongside claims of protocol revenue, staking rewards and token buybacks that could support BNKR demand. Sentiment is largely bullish and accumulation-oriented, though some traders question whether the sharp moves are sustainable or speculative.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxons quarterly results beat expectations, with record refining performance benefiting from tight diesel supplies amid geopolitical disruptions. Traders are broadly positive on the refining-led strength and shareholder returns, while some question whether the unusually strong margins can last.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Inuvo or PubMatic: Which AI Ad-Tech Stock Has the Edge?

PUBM's broader AI-driven ad ecosystem, stronger financials and rapid AgenticOS adoption give it an edge over Inuvo despite a richer valuation.


Can Rising Adoption of IntentKey Accelerate INUV's Long-Term Growth?

Inuvo's IntentKey is gaining enterprise traction as larger campaigns and new markets can help accelerate audience modeling growth.

Inuvo Stock Plunges 22% In A Month: Should You Buy it on the Dip?

INUV's 22% monthly plunge reflects Legacy Search weakness, but rising Audience Modeling growth and IntentKey adoption support a recovery case.

Bear of the Day: Dropbox (DBX)

The stock rebounded along with the broad tech move but the growth just isn't there. 

SYNA Q4 Earnings Beat Estimates, Strong Core IoT Sales Aid Revenues

Synaptics beats fiscal Q4 estimates as Core IoT sales jump 24%, margins expand and operating profit rises, while its pending onsemi deal keeps guidance on hold.

JFrog Q2 Earnings Beat Estimates on Cloud and Security Growth

FROG's Q2 earnings beat estimates as cloud revenues jump 53%, security adoption deepens, and 2026 guidance increases on stronger cloud momentum.


Airbnb Q2 Earnings Beat Estimates as Booking Demand Accelerates

ABNB's Q2 earnings and revenues beat estimates as bookings accelerate, margins expand, and AI gains support a higher 2026 outlook.


Applied Optoelectronics Q2 Earnings Beat Estimates, Revenues Up Y/Y

AAOI's Q2 earnings beat estimates as revenues surge 86.4%, fueled by datacenter, CATV, and rapid 800G growth.


MCHP Q1 Earnings Beat Estimates, Revenues Rise on Demand Recovery

Microchip's fiscal Q1 results beat estimates as demand recovery, inventory normalization and factory utilization lifted sales, margins and cash flow.

Dropbox Q2 Earnings Beat Estimates on Core FSS, 2026 Outlook Raised

DBX beat Q2 2026 earnings and revenue estimates, as improving core FSS trends, paying-user growth and AI expansion support momentum.


Inuvo, Inc. engages in the business of developing and selling information technology solutions for marketing and advertising. Its products and services include IntentKey and Bonfire. The company was founded in October 1987 and is headquartered in Little Rock, AR.

Inuvo Inc

What Triggered INUV Stock’s Sharp Sell-Off Today?

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>H.C. Wainwright slashed its price target on Inuvo to $6 from $10, citing a lower revenue forecast.</li><li>Inuvo said it expects Q4 2025 net revenue of about $14 million, down roughly 47% from a year earlier.</li><li>The company appointed Rob Buchner as Chairman and CEO.</li></ul>Shares of Inuvo Inc. (INUV) sank more than 30% on Thursday after the company flagged a steep fourth-quarter (Q4) revenue shortfall, prompting H.C. Wainwright to issue a sharp price target cut.H.C. Wainwright slashed its price target on Inuvo to $6 from $10, citing a lower revenue forecast, according to The Fly. This still represents a 150% upside from the current price.The firm also noted that revenue headwinds continued into January but highlighted management’s expectation of a rebound in the coming months. H.C. Wainwright reiterated a ‘Buy’ rating on the stock.<h2 class="st-heading-2">Preliminary Q4 Snapshot</h2>Inuvo said it expects Q4 2025 net revenue of about $14 million, down roughly 47% from a year earlier and nearly half of Wall Street’s expectations of $27.3 million, according to Fiscal.ai data.The company said the miss was largely driven by an intentional pullback in the company’s Platform product line, an AI-driven audience modeling tool for advertising. For the full-year 2025, Inuvo expects revenue of about $86 million, representing 3% year-over-year growth but still below analyst estimates of $99.3 million.“During the quarter, we prioritized advertising quality, scalability, and compliance over short-term volume, leading to a near-term reduction in revenue. While we had flagged challenges on our Q3 conference call, the impact ended up greater and more prolonged than expected, extending through Q4 and into January. We have reason to believe that revenue will recover in the months ahead,” said outgoing Inuvo CEO Rich Howe.Separately, the company announced that Rob Buchner has been appointed as Chairman and CEO effective February 1, succeeding Richard Howe, who held the post for 15 years<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>While retail chatter on Stocktwits was ‘high,’ sentiment remained in the ‘neutral’ territory over the past 24 hours.One bullish user sees the sell-off as an overreaction.<stembedurl>https://stocktwits.com/JJJS75/message/643266935</stembedurl>Another user sees the CEO change as a positive development for the company.<stembedurl>https://stocktwits.com/TheLoneWolfWarriorAKABuc/message/643264264</stembedurl><a href="https://stocktwits.com/symbol/INUV">INUV stock</a> has declined more than 50% over the past year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-fslr-stock-decline-today/cmyi0bBR41G">FSLR Stock Slumps 13% On BMO Downgrade – What Is The Tesla Angle?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

The company flagged a steep fourth-quarter revenue shortfall in its preliminary earnings report, prompting H.C. Wainwright to slash the stock’s price target.

Vanguard Total Stock Market ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$INUV got in at $.45; averaged dow to $2.08 from $2.86. ER in ~2 weeks. need that 300% gain lol at least test $1 ffs

Daniel

$INUV Wow, wtf has happened to this company,
earring and revenue was always beating 
Just doesn’t make sense

Native Traditions

$INUV  below 40 cent soon or next week …. 
below 30 cent after next earning ….revenue sharply decreasing ….strong sell or short it …

Jay&amp;Kay

$INUV the same stupid algorithm across many many small in micro cap stocks.  Maybe one day it will turn off

Jmac

$INUV so basically 5 cents pre split price. Wiĺl be taken private or sold for cheap to insiders

Keith Redman

$INUV ER in one month. this pos is probably going to hit $.20 and theyre going to do another r/s. corrupt mfs

$INUV  below 50 cent soon ….below 40 cent after earning ….revenue sharply decreasing … 
strong sell or short it …below 30 cent EOY …

$INUV insane! the SP manipulation continues. $.50 again, soon. lets see it it rebounds like it did last week

$INUV still a lot of money left on the table for execs and board members holding shares, they will find a buyer of the company

Louis

$INUV  short squeeze incoming …. 
it will be below 40 cent after next earning …. 
strong sell or short it …20 cent by end of year

Feed

News

Sentiment

Earnings

Fundamentals

Info

INUV Inuvo Inc

Fundamentals

Latest INUV News